{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:46:25Z","timestamp":1793490385585,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences Tabriz","doi-asserted-by":"publisher","award":["94\/5-9\/7"],"award-info":[{"award-number":["94\/5-9\/7"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jneuroim.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T01:55:13Z","timestamp":1547690113000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis"],"prefix":"10.1016","volume":"327","author":[{"given":"Sanam","family":"Dolati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Babaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hormoz","family":"Ayromlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Rikhtegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Rostamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Roshangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Mehdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Younesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2019.01.007_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.04.012","article-title":"Altered frequency of T regulatory cells is associated with disability status in relapsing\u2013remitting multiple sclerosis patients","volume":"249","author":"Bjerg","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/963748","article-title":"Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis","volume":"2013","author":"Buc","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.10.014","article-title":"IFN-\u03b2 induces the proliferation of CD4+ CD25+ Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis","volume":"242","author":"Chen","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing\u2212 remitting multiple sclerosis","volume":"182","author":"de Andr\u00e9s","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biopha.2016.12.010","article-title":"Multiple sclerosis: Therapeutic applications of advancing drug delivery systems","volume":"86","author":"Dolati","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0040","first-page":"1","article-title":"Peripheral Th17\/Treg imbalance in elderly patients with ischemic","author":"Dolati","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","article-title":"Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis","volume":"61","author":"Dolati","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017988","article-title":"Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients","volume":"6","author":"Fritzsching","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(10)05004-2","article-title":"The family of IL-10-secreting CD4+ T cells","volume":"105","author":"Fujio","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.fct.2015.05.022","article-title":"The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update","volume":"83","author":"Ghosh","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2009.06.011","article-title":"Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+ CD25+ FOXP3+ CD31+ T-cells in patients with multiple sclerosis","volume":"216","author":"Haas","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0070","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","article-title":"Induction of CD4+ CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3","volume":"102","author":"Hong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0075","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1002\/jcp.26604","article-title":"Regulatory T and T helper 17 cells: their roles in preeclampsia","volume":"233","author":"Hosseini","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0090","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment","volume":"35","author":"Naksuriya","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0095","first-page":"567","article-title":"The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"Rahimi","year":"2016","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.jneuroim.2019.01.007_bb0105","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/jphp.12611","article-title":"Curcumin as potential therapeutic natural product: a nanobiotechnological perspective","volume":"68","author":"Shome","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0110","first-page":"1","article-title":"Immunomodulatory potential of nanocurcumin-based formulation","author":"Trivedi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-008-9251-y","article-title":"TGF-\u03b2 and regulatory T cell in immunity and autoimmunity","volume":"28","author":"Wan","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intimp.2010.08.013","article-title":"Curcumin has bright prospects for the treatment of multiple sclerosis","volume":"11","author":"Xie","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2019.01.007_bb0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","article-title":"Therapeutic applications of curcumin nanoformulations","volume":"17","author":"Yallapu","year":"2015","journal-title":"AAPS J."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:32:56Z","timestamp":1759048376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818304661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"alternative-id":["S0165572818304661"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}